HUTCHMED Announces Board of Directors Structure
Company Announcements

HUTCHMED Announces Board of Directors Structure

HUTCHMED (China) Limited (HK:0013) has released an update.

HUTCHMED (China) Limited has announced the composition of its Board of Directors, which includes a total of nine members, with Dr. Dan Eldar serving as Chairman. The list comprises both executive and non-executive directors, as well as independent non-executive directors, each with specific committee roles and responsibilities. The details regarding committee memberships, including audit, nomination, remuneration, sustainability, and technical committees, have been provided to outline the governance structure.

For further insights into HK:0013 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyHutchmed announces new, updated data from sovleplenib ESLIM-01 trial
TipRanks HongKong Auto-Generated NewsdeskHUTCHMED to Present Promising Clinical Data in 2024
TheFlyHutchmed to receive $20M milestone payment from Takeda for Fruzaqla sales
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App